Form 483

1ViZN LLC Form 483, 2017-02-28

FDA issued a Form 483 to 1ViZN LLC on 2017-02-28 with 9 public-safe observations.

483· Form 483 issuedFoods & Cosmetics9 observations

1ViZN LLC · Springville, United States · Issued February 28, 2017

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Feb 2017
21 CFR 111.103

Written procedures - quality control operations

Cited by Matthew A Johnson

28 Feb 2017
21 CFR 111.65

Quality control - quality, dietary supplement

Cited by Matthew A Johnson

28 Feb 2017
21 CFR 111.105(g)

Quality control - reserve samples

Cited by Matthew A Johnson

28 Feb 2017
21 CFR 111.165?

Product received - quarantine

Cited by Matthew A Johnson

28 Feb 2017
21 CFR 111.70(b)(2)

Specifications-component purity, strength, composition

Cited by Matthew A Johnson

Inspected site

1L1ViZN LLCSpringville, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.103Cited across public-safe Form 483 observations1x
21 CFR 111.105(g)Cited across public-safe Form 483 observations1x
21 CFR 111.165?Cited across public-safe Form 483 observations1x
21 CFR 111.165(c)Cited across public-safe Form 483 observations1x
21 CFR 111.65Cited across public-safe Form 483 observations1x
21 CFR 111.70(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.70(e)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.75(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere